NCT01259323: Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis
- State
- Completed
- Phase
- Phase 1
- People
- 30 taking part
- Started
- Dec 2010
- Primary completion
- Jul 2012
- Arms
- Cohort 1, Cohort 2, Cohort 3
- Results
- None posted
- 14 Dec 2010: Trial registered